about
Induced urinary crystal formation as an analytical strategy for the prediction and monitoring of urolithiasis and other metabolism-related disorders.Use of ibandronate in the prevention of skeletal events in metastatic breast cancer.Treatment of renal sarcoidosis: is there a guideline? Overview of the different treatment options.
P2860
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Nephrotoxicity related to new therapeutic compounds.
@ast
Nephrotoxicity related to new therapeutic compounds.
@en
Nephrotoxicity related to new therapeutic compounds.
@nl
type
label
Nephrotoxicity related to new therapeutic compounds.
@ast
Nephrotoxicity related to new therapeutic compounds.
@en
Nephrotoxicity related to new therapeutic compounds.
@nl
prefLabel
Nephrotoxicity related to new therapeutic compounds.
@ast
Nephrotoxicity related to new therapeutic compounds.
@en
Nephrotoxicity related to new therapeutic compounds.
@nl
P2860
P356
P1433
P1476
Nephrotoxicity related to new therapeutic compounds.
@en
P2093
Cheuk Chun Szeto
Kai Ming Chow
P2860
P304
P356
10.1081/JDI-56595
P577
2005-01-01T00:00:00Z